
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
[ Fri, Aug 06th 2021 ]: WOPRAI
Keay Nakae Maintained (ARWR) at Strong Buy with Decreased Target to $94 on, Aug 6th, 2021


🞛 This publication is a summary or evaluation of another publication
Keay Nakae of Chardan Capital, Maintained "Arrowhead Pharmaceuticals, Inc." (ARWR) at Strong Buy with Decreased Target from $97 to $94 on, Aug 6th, 2021.
Keay, nor any peers, have made any analyst calls on ARWR in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30